5AM Ventures’ Post

5AM Ventures reposted this

View organization page for NodThera, graphic

3,618 followers

We are pleased to welcome Daniel Swisher as Chief Executive Officer! Dan joins the team with more than 30 years of leadership expertise in the #LifeSciences industry. During his career, he has led the advancement and commercialization of novel therapeutics in multiple therapeutic areas, including #neuroscience and #RareDiseases, and has significant experience in driving cross function, high-performing teams and relationship building. NodThera’s founder and interim CEO, Alan Watt, becomes our President and CSO, responsible for growing the Company’s R&D organisation and strengthening our world-leading position in #NLRP3 #inflammasome research. Find out more here: https://lnkd.in/d4vYKka7 #Appointment #NewHire #NeuroInflammation #WelcomeToTheTeam

Daniel Swisher

C-Suite Biopharma Executive and Board Member

4mo

Very excited to be here with this outstanding team, science and growing data sets.

Like
Reply

Great to have you on board Dan!

Rab Prinjha

Former Head of Immunology Research at GSK. A strategic and effective leader bringing deep experience in successful R&D. I have an outstanding track record of serial successes and excellent R&D portfolio delivery.

4mo

Congratulations Alan Watt on the news roles and securing such a great CEO in Daniel Swisher for @Nodthera

Like
Reply
Laia Crespo

Partner - Sanofi Ventures

4mo

Welcome Dan ! look forward to working together

Like
Reply
Naveed Siddiqi

Senior Partner, Novo Holdings

4mo

Great news!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics